ArticleClinical and translational science2021

Pharmacoenhancement of Low Crizotinib Plasma Concentrations in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer using the CYP3A Inhibitor Cobicistat.

Nicolas Hohmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.